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Rapid thrombus formation at the beginning  
of a catheter ablation procedure  
for persistent atrial fibrillation
Szybkie utworzenie się skrzepliny na początku zabiegu ablacji cewnikowej 
przeprowadzonej z powodu utrwalonego migotania przedsionków
Josef Kautzner, Petr Peichl, Tomas Marek
Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
A 59-year-old woman with a history of arterial hypertension and 
myocardial infarction of embolic origin (LVEF 35–40%) was referred 
in 2010 for catheter ablation of long-term persistent atrial fibrillation 
after 4 previous ablation procedures performed abroad. She presented 
with palpitations and dyspnoea. Warfarin was interrupted (INR 1.4) and 
enoxaparin 40 mg sc bid was initiated. Transoesophageal echocardio-
graphy was performed under general anaesthesia at the beginning of 
the procedure showing enlarged left atrium, spontaneous echocontrast, 
low left appendage velocities (v = 20 cm/s) with some degree of sludge 
and absent thrombus (Fig. 1A). Within a few minutes after the introduc-
tion of single diagnostic catheter into the coronary sinus, well before 
transseptal puncture, fresh thrombus formation was observed in the left 
atrial appendage (Figs. 1B, C — arrow). Unfractionated heparin was ad-
ministered intravenously activated clotting time (ACT) ≈ 350 s) and the 
thrombus gradually resolved within 30 min. Subsequently, transseptal 
puncture was performed and re-isolation of the left pulmonary veins 
terminated the arrhythmia. Residual perimitral flutter was ablated at the 
mitral isthmus. No other arrhythmia was inducible and the patient has 
gone 43 months without any recurrence of arrhythmia. She continues 
anticoagulation therapy with warfarin. This case report challenges the 
common practice of administering heparin after transseptal puncture 
and maintaining ACT level during the procedure around 250 s. Several 
groups have confirmed that the risk of thrombus formation under such 
conditions could be as high as 10%. Early administration of heparin 
before transseptal puncture and increased intensity of anticoagulation 
(ACT > 300 s) were documented to prevent left atrial thrombus forma-
tion. Uninterrupted administration of warfarin may further decrease 
the risk of intraprocedural thromboembolic events.
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Figure 1. A–C. Rapid thrombus formation at the 
beginning of catheter ablation procedure for 
persistent atrial fibrillation (arrow)
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